Bank Of New York Mellon Corp Chembio Diagnostics, Inc. Transaction History

Bank Of New York Mellon Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.25 - $0.45 $30,761 - $55,370	123,045 New	123,045 $54.4 Million
Q4 2022 Feb 14, 2023	BUY	$0.2 - $0.33 $24,609 - $40,604	123,045 New	123,045 $27,000
Q2 2022 Aug 15, 2022	SELL	$0.45 - $0.8 $359 - $638	-798 Reduced 0.64%	123,952 $81,000
Q1 2022 May 11, 2022	BUY	$0.66 - $1.23 $82,335 - $153,442	124,750 New	124,750 $102,000
Q3 2021 Nov 12, 2021	SELL	$2.06 - $5.34 $29,837 - $77,344	-14,484 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$2.88 - $5.64 $144,135 - $282,265	-50,047 Reduced 77.55%	14,484 $43,000
Q1 2021 May 13, 2021	SELL	$3.4 - $7.97 $2,036 - $4,774	-599 Reduced 0.92%	64,531 $226,000
Q4 2020 Feb 09, 2021	BUY	$4.11 - $7.51 $66,055 - $120,700	16,072 Added 32.76%	65,130 $309,000
Q3 2020 Nov 12, 2020	SELL	$3.28 - $5.93 $6,323 - $11,433	-1,928 Reduced 3.78%	49,058 $238,000
Q2 2020 Aug 12, 2020	BUY	$3.18 - $15.54 $162,135 - $792,322	50,986 New	50,986 $165,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.